Funding Invest Platform Thousand Oaks 
socalTECH
MAY 8, 2012
The venture capital arm of Thousand Oaks-based Amgen has placed more funding into one of its portfolio companies, Sutro Biopharma , which is working on developing a scalable biochemical protein synthesis platform aimed at cancer therapeutics. Sutro said it has raised $16.5M
socalTECH
OCTOBER 29, 2015
in a funding round. I grew up in Thousand Oaks, went to USC, and we met each other way back in the 90's. Brew Johnson: At the high level, it's a marketplace, a lending platform for real estate. One, is how to create a more scalable and efficient platform. Brett and I both grew up in Southern California.
Expert insights. Personalized for you.
140 
Let's personalize your content